Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
featured

Journal Scan / Research · October 11, 2019

Benefit and Risks of Aspirin Plus Ticagrelor in ACS

JAMA Cardiology

 

Additional Info

JAMA Cardiology
Benefit and Risks of Aspirin in Addition to Ticagrelor in Acute Coronary Syndromes: A Post Hoc Analysis of the Randomized GLOBAL LEADERS Trial
JAMA Cardiol 2019 Sep 26;[EPub Ahead of Print], M Tomaniak, P Chichareon, Y Onuma, EN Deliargyris, K Takahashi, N Kogame, R Modolo, CC Chang, T Rademaker-Havinga, RF Storey, GD Dangas, DL Bhatt, DJ Angiolillo, C Hamm, M Valgimigli, S Windecker, PG Steg, P Vranckx, PW Serruys

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading